The scramble to develop treatments for Covid-19 has paid off. Since the disease first emerged, medical professionals have gone from fumbling in the dark to a better understanding of what drugs work. In November, U.S. regulators granted emergency authorization for the use of two antibody therapies, adding to the arsenal of Covid-19 treatments.
Source link : https://www.washingtonpost.com/business/where-are-we-in-the-quest-forcoronavirustreatments/2020/11/23/6b13f5f2-2da6-11eb-9dd6-2d0179981719_story.html?utm_source=rss&utm_medium=referral&utm_campaign=wp_business
Author : By John Lauerman | Bloomberg
Publish date : 2020-11-24 17:44:02
Copyright for syndicated content belongs to the linked Source.
- UNITED KINGDOM
- UNITED STATES